中文名称:B细胞因子3检测试剂盒 英文简称:Bcl-3 英文全称:B-cell leukemia;lymphoma 3 检测范围:3.125ng/mL~100ng/mL 灵敏度:0.1 货号: FS13944 试剂准备: 1. 使用前将所有的试剂和标本缓慢均衡至室温(18-25oC),试剂不能直接在37oC溶解。 2. 标准品(冻干品):每瓶标准品加入标准品稀释液1mL,盖好后室温...
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Mol Cancer Res. 2021 Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large ...
参考资料 [1]Abramson J S,et al.Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial[J]. The Lancet, 2024, 404(10466): 1940-1954. https://www.thelanc...
该B-Cell CLL/Lymphoma 3 (Bcl3) Recombinant, Rat产品的产品序列,详细查看产品说明书。来源宿主 提供的B-Cell CLL/Lymphoma 3 (Bcl3) Recombinant, Rat来源为Recombinant Rat from E. coli。溶解建议 艾美捷向您提供的USBiological品牌B-Cell CLL/Lymphoma 3 (Bcl3) Recombinant, Rat产品为原装进口产品。请按照...
参考文献 Alexandra E Rojek, Sonali M Smith.Evolution of therapy for limited stage diffuse large B-cell lymphoma.Blood Cancer J . 2022 Feb 24;12(2):33. doi: 10.1038/s41408-021-00596-z.
患者群体特征:纳入的 283 例患者中位年龄 66 岁,弥漫性大 B 细胞淋巴瘤未另行分类(Diffuse Large B - cell Lymphoma Not Otherwise Specified)占比 77% 。CAR - T 治疗后,总体缓解率(Overall Response Rate,ORR)为 80%,完全缓解(Complete Response,CR)率为 64% 。2 年无进展生存期(Progression - Free Su...
产品名称:B-cell lymphoma/leukemia 10 ELISA Kit 检测范围: 保存条件:2-8℃低温保存 保质期:6个月,所有试剂盒均提供批次。 试剂盒成分:酶标板,试剂,标准品等。 操作步骤 1.标准品的稀释:本试剂盒提供原倍标准品一支,用户可按照下列图表在小试管中进行稀释。 2.加样:分别设空白孔(空白对照孔不加样品及酶标...
3.Witzig TE, Vukov AM, Habermann TM, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Gro...
①效应性B细胞(effector B cell,Beff)可产生自身抗体,如类风湿因子(rheumatoid factor,RF)和抗瓜氨酸蛋白抗体(anti-citrulline protein antibody,ACPA)等,这些抗体形成免疫复合物,沉积在关节中,并通过补体和细胞激活促进炎症过程;②B细胞作为有效的抗原提呈细胞(antigen presenting cell,APC),通过共刺激分子的表达激活...
3, Jin-Hua Liang1, Zhen Wang3, Li Wang1, Lei Fan1, Dong Hua2,Yao-Yu Chen1, Wei Xu1, Zhi-Hong Zhang3 & Jian-Yong Li1,4 Using an immunohistochemistry (IHC) based method, diffuse large B-cell lymphoma (DLBCL) can be classified into germinal center B-cell (...